IN BRIEF: Ondine says photodisinfection effective against Sars-CoV-2
Ondine Biomedical Inc - Vancouver, Canada-based life sciences company focused on photodisinfection-based therapies - Says its Steriwave photodisinfection laser technology was 99.99% effective at inactivating Sars-CoV-2, the virus that causes Covid-19, in mammalian cell culture. This inhibits infectivity, the firm adds. Citing a new study published in the Journal of Photochemical & Photobiological Sciences, the study "reconfirmed that a single dose of photodisinfection is capable of destroying both the Sars-CoV-2 viral spike and viral genome, reducing viral load to below detection limit within five minutes," Ondine says. Read More